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THE ZIRCONIUM DEODORANT GRANULOMA:
AN ALLERGIC DISORDER*
HARRY J. HURLEY, JR., M.D., D.SC. (Med.) ** AND WALTER B. SHELLEY, M.D., Ph D.**

Within the last few years, a new and unusual disorder has been described in the
dermatologic literature. This disease showed striking uniformity both clinically and
histologically'''-^''*'''', although it was given a variety of names, including axiflary
granulomas, sarcoid-like eruption of the axillae, granulomatous reaction to deodorant
sticks, granulomas of the axillae caused by deodorants, and zirconium granulomas.
It was characterized by the presence of persistent painless papules, with minimal acute
inflammation and pruritus, appearing in the axillae of persons who had used zirconiumcontaining deodorants (Figure 1). Histologically, a distinctive granulomatous reaction
was seen and was diagnostic (Figure 2 ) . This eruption proved to be virtually refractory
to all forms of treatment and its course, following cessation of the deodorant, was one
of very gradual, spontaneous involution.

Figure 1
Clinical appearance of axillary zirconium deodorant granulomas.
This patient, a 36-year-old white housewife, developed numerous red-brown papules in the axillae a
few months after daily application of a zirconium stick deodorant. Despite cessation of the deodorant
the lesions persisted for over two years.
*Presented before the Henry Ford Hospital Medical Society, April 8, 1958.
'•Department of Dermatology, School of Medicine, University of Pennsylvania, Philadelphia, Penn.
This work was supported in part by a research grant (RG-4232 C3) from the Division of Research
Grants, National Institutes of Health, United States Public Health Service.
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Figure 2
Biopsy of one of the axillary lesions shown in Figure 1 revealed characteristic sarcoid-type of granulomatous patterning. In the upper photograph a low power (x70) microscopic view of the lesion
shows nests of epithelioid cells replacing much of the normal dermis. In the lower photograph under
higher power (x250) the cytologic appearance of the granulomatous infiltrate is visualized. A giant
cell of the so-called Langhan's variety is evident in the upper right hand corner.
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Great interest was evinced in this disorder and, in less than two years (1956 to
1958), some 70 cases were described in the literature and a variety of speculations
made as to its etiology. Prominent among these were foreign body reactions to
zirconium''^ to contaminant metals such as beryllium' or hafnium', to the lipid'''", or
other inert ingredients of the deodorant vehicle", and secondary apocrine sweat extravasation'^ or follicular wall degeneration'^ However, there was little or no experimental
support for any of these possibflities, and neither the incitant or incitants nor the
mechanism by which the disease was produced were identified.
In this paper we should like to review our experimental and clinical studies of
this distinctive new dermatosis. We have elected to call this new condition the zirconium
deodorant granuloma. As a result of these observations, we have concluded that the
axfllary granulomas that develop incident to the use of zirconium deodorants are the
result of a specific allergic hypersensitivity to the metal zirconium which manifests
itself as a stable, sarcoid-like granuloma.
The Zirconium

Deodorant

Stick

It should be emphasized that no single deodorant preparation had been used
by all of the patients described in the literature. However, the vast majority had
applied a new stick-type deodorant containing sodium zirconium lactate. This stick
was essentially a soap-alcohol-gel composed of sodium stearate, ethyl alcohol, carbitol
and water with approximately 10% of an aqueous solution of sodium zirconium
lactate, and small amounts of hexachlorophene and a perfume incorporated into the
basic gel.
Each of the components of this stick alone or in combination was suspect in
the production of this granulomatous disorder. However, it was difficult to predict
which of these substances was causal. The sodium stearate seemed a quite unlikely
candidate since the daily use of soap for years by many milllions of people on broken
and unbroken skin has never produced a single granuloma. Similarly the ethyl
alcohol, while at times capable of producing transient irritation, has never been known
to induce such chronic change despite its ubiquity in cosmetic and topical medicinal
products. Carbitol/diethylene glycol mono-ethyl (ether) as a congener of glycerine
is miscible with water and extensive studies have indicated that it is essentially nonirritating to rabbit skin'^. However, absorption of large amounts of carbitol can prove
fatal to these animals. Hexachlorophene has been used for many years as a germicide
for surgical scrubs. It has also been employed topically in creams and lotions on adult
and infant skin without ill effect. The very small quantities of perfume that were
present in the stick would seem to make it an unlikely possibility also.
Of all the ingredients of the stick deodorant, zirconium loomed as the most logical
canidate for the granulomagenic agent. Indeed, the majority of observers were of
the opinion that it was in some way responsible, since the appearance of this new
granuloma coincided with the introduction of zirconium in deodorants. Zirconium,
a metaflic element in group IV period V of the periodic table, is normally found in
the earth's crust as an oxide or siflcate in a concentration of about 0.22%. I t is
not radio-active and is closely related to hafnium chemically. Actually, as much as
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2% hafnium has been found in the purest zirconium preparations. Sodium zirconium
lactate is a recently synthesized salt. It is used as a 40-45% aqueous solution (Ph7.5-8.2) which is compatible with soap. In the axilla its primary action is as a
deodorant and it produces this effect apparently by reducing the surface bacterial
flora and probably also by forming a complex with the malodorous fatty acids. Any
antiperspirant effect fl may achieve is the result of eccrine poral closure in a manner
similar to that of the aluminum salts. However, in the axilla this effect is not
remarkable.
Zirconium has long been regarded as a very inocuous substance. Careful toxicologic studies support this'''"'". As a metal fl has been employed successfully in
surgery as bone screws, cranial plates, intrameduflary pins, sutures, and bone clips".
In animals its introduction in both soluble and insolube forms parenterally, by ingestion
and by inhalation for as long as two years has not produced significant acute or
chronic change"'20.2i,22. Granulomas have not been reported in men working with
zirconium in industry nor have pulmonary changes been observed. Its use topically
(4% zirconium dioxide ointment) in patients with poison ivy dermatitis has not
proved harmful"'". Even intravenous administration of zirconium salts has been
safely employed in patients wflh pyodermas". The consensus of opinion was that
zirconium in any form seemed to be a safe and essentially harmlesss compound for
man. Thus, despite the circumstantial evidence incriminating zirconium as the granulomagenic substance, there was little in the literature to support such suspicion.
Moreover, it should be pointed out that the new stick-type vehicle used in these
deodorants was of very recent vintage also, and this lent credence to the view that
one of the components of this stick or a contaminant was responsible. It thus became
apparent that only through careful experimental study could one identify the substance
or substances responsible for this new dermatosis.
Experimental

Studies

It was stated earlier that as a result of extensive experimental investigation we
concluded that the zirconium deodorant granulomas were the result of an allergic
hypersensitivity of these patients to the metal zirconium. These studies have been
carefully detailed in another report". They were carried out under controlled conditions
in healthy adult male volunteers. They may be summarized briefly as follows:
(1) Experimental production of histologically proved axillary granulomas identical
with those of clinical cases was achieved in two (subject No. 2 and subject No. 35)
of fifty subjects by the daily intensive (5 minutes) application to the axillae of
deodorant sticks containing sodium zirconium lactate in both 5 and 10% concentrations. Sticks containing zirconium in 1% concentration produced no such reaction.
These granulomas were typically chronic persisting for as long as six months following
cessation of the zirconium deodorant sticks. Several other subjects developed transitory
acute inflammatory changes to the 5 and 10% zirconium sticks, but these reactions
were cleariy non-granulomatous histologically. Control sticks, identical except for
the absence of zirconium, failed to produce any acute inflammation or granuloma in
any of the fifty subjects.
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(2) Zirconium deodorant sticks deleted of the hexachlorophene, carbitol, and
perfume regularly found in the commerciafly available sticks, were equally capable
of inducing the granulomatous reaction.
(3) Substitution of 5% aluminum chloride for the sodium zirconium lactate in
the deodorant sticks failed to result in the development of axiflary granulomas.
(4) There was no epidermal (contact) sensitivity to zirconium or any of the
other ingredients of the deodorant stick as evidenced by routinely negative patch tests
to the deodorant sticks in afl of the experimental .subjects.
(5) Intradermal injections of dilutions of aqueous solutions of zirconium salts
reproduced the granulomatous reaction in the two subjects (No. 2 and No. 35) in
whom the axillary granulomas were seen to develop. Injection of these zirconium
salts in many normal control subjects and injection of all other ingredients of the
deodorant stick, as well as other representative metals (beryllium and sflicon) in
subjects No. 2 and No. 35, and in the control subjects, failed to produce any such
response. Table I depicts the results of these studies.
(6) In a concentration of 1:10,000 aqueous solutions of soluble salts of fiftyseven elements of the periodic table also were injected intradermally in the subjects
No. 2 and No. 35, and in the twenty control subjects. In all of the men so treated
there were no granulomatous reactions at any of the injection sites except at that
of zirconium in subjects No. 35. It is to be recalled that he responded simflarly to
1:10,000 zirconium in the previous series of injections (Table I ) . The elements that
were included in this second series of intradermal tests included:
Aluminum
Antimony
Arsenic
Barium
Beryllium
Boron
Bromine
Cadmium
Cerium
Cesium
Chromium
Cobafl
Dysprosium
Erbium

Europium
Fluorine
Gadolinium
Gallium
Germanium
Hafnium
Holmium
Indium
Iodine
Iridium
Lanthanum
Lead
Lflhium
Lutetium

Manganese
Mercury
Molybdenum
Neobium
Neodymium
Nickel
Palladium
Praesodymium
Rhenium
Rhodium
Rubidium
Ruthenium
Samarium
Scandium

Silicon
Silver
Strontium
Tantalum
Tellurium
Terbium
Thulium
Tin
Titanium
Tungsten
Vanadium
Ytterbium
Yttrium
Zinc
Zirconium

These experimental studies indicated that zirconium and zirconium alone was
the critical substance responsible for the development of the granulomatous reactions
seen in this disorder. Furthermore, the pathogenesis of these granulomas was shown
to be the result of a specific hypersensitivity, probably allergic in nature, to the
metal zirconium.
Our next step was to confirm these findings in clinical patients with the zirconium
deodorant granulomas.
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Table I

Intradermal
Injections
(0.02 cc)
to

Sodium Zirconium Lactate
1 : 1(10 1:1000
1:10,000
1:100,000

Zirconium
Chloride
1 :l()O0
1:10,000

Zirconium
Nitrate
1:1000 1:10,000

Beryllium
Sulphate
1:1000

Colloidal
Silica
1:1000

Other
Components of
Deodorant
Stick*
1:1000

3:

Subject No. 2

+

-1-

0

0

+

0

-1-

0

0

0

0

3

Subject No. 35

+

+

+

0

+

+

+

+

0

0

0

=^
—

Controls (20)

0

0

0

0

0

0

0

0

0

0

0

*The various ingredients of the stick were injected alone and in combination in the above concentrations. They included sodium stearate, hexachlorophene, ethyl alcohol, carbitol, and perfume.
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Clinical Studies
Four patients wflh zirconium deodorant granulomas were available for study.
All had the typical histologically proved granulomatous lesions in the axillae and all
were in good health. A battery of general medical studies were within normal limits
on all of these patients. These patients were women, ranging in age from 23 to 42
years. Three of the four women had used the zirconium stick deodorant for at least
two months prior to the appearance of the eruption. However, one patient states
that the lesions appeared after only two applications of the stick. In each case all
forms of treatment, including topical steroids, were ineffective. The chronicity of
the lesions was an outstanding feature in these patients, and in one patient residual
papules were stifl visible over two years after cessation of the zirconium stick and
other deodorant applications.
Special studies performed on these patients included:
(1) Intradermal injection (0.02 cc.) of 1:1000 and 1:10,000 dilutions of aqueous
sodium zirconium lactate solution produced a papule in 10 days in three of the four
patients. On biopsy these papules showed the characterstic granulomatous picture.
The fourth patient responded similarly only to the 1:1000 dilution of the zirconium
solution. None of the four patients showed any visible response to 1:100,000 sodium
zirconium lactate.
(2) Intradermal injections (0.02 cc.) of 1:1000 beryllium sulfate and 1:1000
silicon dioxide were negative in all four patients. Patch tests to zirconium deodorant
stick (full strength) were negative at 72 hours in all four subjects. However, in one
subject, a small papule (Figure 3) appeared at about one month. Although involuting

WmaBB
Figure 3
Granulomatous reaction appearing al site of patch test to zirconium stick deodorant. Four to five
weeks after a negative response (72 hours) to a closed patch test to a standard zirconium stick
deodorant, a papule (shown above) appeared in the patch test site in one of our clinical patients.
Histologically this papule showed granulomatous change comparable to that seen in the axillary
granulomas.
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gradually, it was still evident six months later. This lesion was simflar clinically to the
axillary granulomas and proved to be granulomatous histologically also.
Discussion
The metals, silicon and beryflium, have long been known to be capable of
inducing cutaneous granulomas in some individuals after accidental inoculation"'''.
In order to determine the presence or absence of these metals as contaminants, we had
spectrographic analyses performed on the commercial sodium zirconium lactate solution used in our studies. Many elements were tested for and several were found to
be present, in addition to the major constituent, zirconium. Silicon was detected in
a concentration of about 0.008%, but beryllium was not found. A l l of the other
elements found were in similariy low concentration and included aluminum, boron,
calcium, chromium, iron, magnesium, nickel, and strontium. These were included in
the test series of injections made on the experimental subjects, it should be recalled,
and were found to be incapable of elicfling a granulomatous reaction.
Although a perusal of these studies leaves little doubt that these patients manifested a hypersensitivity to zirconium, that this hypersensitivity was allergic in nature
requires further amplification.
Allergic states are acquired, not inherited. Although we have no skin tests or
other information indicating the lack of allergic hypersensitivity of these individuals
prior to their exposure to the zirconium deodorant sticks, we may presume that they
had no such prior hypersensitivity. This hypersensitivity developed some time during
the period of application of the deodorant sticks. More compelling evidence that this
zirconium hypersensitivity is acquired is avaflable in another experimental subject (not
recorded here and not a part of these studies) in whom initially negative intradermal
injections of zirconium became granulomatous several months later. Careful study of
this subject verified the specific hypersensitivity to zirconium.
Allergic states are specific. The specificity of the reactivity of these subjects to
zirconium should be apparent after a review of the data outlined above. Moreover,
the abflity to respond to great dilutions of the zirconium points to the allergic nature
of this unusual reaction.
Demonstration of an antigen-antibody reaction is an important and ultimately
requisite step in the confirmation of allergic reactions. We are studying this problem
at the moment. Classical serological tests and serum passive transfer techniques for
the demonstration of antibody have not been of value possibly because the antibody
concerned with this form of allergy may well be cellular. Modified cell transfer
methods and other in vivo and in vitro methods are being employed at present.
The failure to identify the antibody concerned with the hypersensitivity reaction
to zirconium in the cases described herein does not invalidate our thesis that this
reaction is truly allergic in nature. It should be recalled that other forms of allergy
were well accepted as such many years before any antibody was ever demonstrated.
Tuberculin allergy and contact allergy are excellent examples in point. It is only
wflhin recent years by means of specialized cell transfer techniques that these forms
of allergy have realized antibody demonstration.
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In the axillary zirconium deodorant granulomas which are seen clinically, the
possible route or routes of entry of the zirconium have caused much discussion. In
women, in whom this disease has occurred predominantly, shaving of the axillary
hair is such a common practice that it was regarded as an important factor in the
development of this dermatosis. Indeed, in one of our experimental subjects in whom
we produced the deodorant granulomas, the lesions could be clearly seen to develop
in a linear shaving cut. However, they have also been observed beneath focal areas
of miliaria. Actual streaming of microparticulate material through the miliarial vesicles
and down into the dermis could be observed histologically. It is our feeling that any
process, dermatitic or traumatic, which destroys the integrity of the epidermis or its
impermeable barrier will allow for ready absorption of the essential granulomagenic
substance, zirconium. Actually, in these hypersensitive individuals, it is likely that
enough zirconium is absorbed through the major normal route of absorption, the
pilosebaceous apparatus.
Further consideration of the natural history of the zirconium deodorant granuloma
as it relates to the allergic process is in order. The affected patients almost uniformly
give a history of having used a zirconium-containing product for weeks to months
prior to the appearance of their papular eruption. This, then, is the period in which
the patients are non-allergic and will not react in this fashion to zirconium. In the
latter part of this period they become sensitized to the zirconium. Once this sensitivity
arises, residual or additional zirconium in the skin results in a delayed allergic granuloma formation. This latter phase, the development of the granuloma following exposure to the zirconium in the sensitized individuals, represents the reaction time. For
this form of allergy the reaction time is about two to three weeks for the development
of a mature, fully-formed granuloma, although in more sensitive individuals, it may
be shorter. In a few patients, the granulomatous reaction developed after what was
believed to be the initial contact with zirconium. In these instances, which must be
quite uncommon, we can assume that the patient had had prior exposure to zirconium,
possibly as an inhalant, with prior sensitization. The concentration of zirconium in the
deodorant sticks which will elicit the granulomatous response after topical application
was shown to be 4% or above. However, it is possible that in more sensitive subjects
one might expect even trace amounts of zirconium in any deodorant or other topical
preparation to produce this response. We have no evidence as to the critical concentration necessary to induce sensitization to zirconium, but would feel that as with
other forms of allergy, higher concentrations would more readily produce this effect.
Treatment of the zircoruum deodorant granuloma has been generally disappointing.
Systemic steroid therapy may produce temporary improvement and local injection of
hydrocortisone may induce resolution of the lesions. This is quite in keeping with the
allergic nature of the disorder. Topical treatment is ineffective in reducing or clearing
the basic granulomatous process and is usually unnecessary for the management of any
secondary acute inflammatory changes or pruritus since the latter are not prominent
features of the condition. Cessation of zirconium deodorants and avoidance of all
zirconium-containing products is necessary, of course, and eventually within 1-3 years
the granulomatous lesions wifl involute spontaneously. It is quite probable that this
clinical entity, the zirconium deodorant granuloma, wfll rarely be seen in the future
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since zirconium has been removed from the market as a deodorant. However, individuals who have developed such sensitivity should be advised to avoid further contact
with zirconium. This allergic sensitivity is not locaUzed to any area of the skin nor
to the skin alone. It is generalized in nature and it is conceivable that a granulomatous
"zirconiosis" of the lungs could ensue after inhalation of the element in industry or
accidentally in dust in a given area of the country. Furthermore, it would seem
judicious to re-examine the use of zirconium in surgical plates, intramedullary pins,
sutures and the like in certain patients.
In an earlier part of our study we learned that a granuloma develops when
appreciable quantities of sodium stearate were introduced into the dermis. Initially we
were convinced that this substance was responsible for the deodorant stick granulomas.
However, we later came to realize that this was not the case, and that sodium stearate
was producing a simple, non-allergic granuloma of the foreign-body type. In another
paper we have recorded our findings with this non-aflergic granuloma". Sodium
stearate is not responsible for the clinical axiflary granulomas seen since: (1) large
quantities of sodium stearate are required to produuce the granulomatous response,
(2) stearate granulomas resolve within a few weeks, (3) stearate will elicit granulomas
regularly in every individual, and (4) patients with clinical deodorant granulomas
show the normal response to stearate. However, the most spectacular distinction
between the allergic and non-allergic granulomas relates to the quantity which one
must inject in order to produce the two responses. In the zirconium granuloma, it
is necessary to inject only a fraction of a microgram. With the stearate, in order to
produce a comparable but non-allergic lesion, there must be a thousandfold increase
in the quantity introduced.
The zirconium deodorant granuloma is a prototype of the allergic granulomas
seen in man. Histologically it is composed of nests of epithelioid cells, without central
necrosis or caseation and with minimal associated inflammatory reaction. The development of this pattern and its immutability for months to years, once its peak has been
reached, are outstanding features of this type of granuloma. There is no piecemeal
destruction of a central mass of insoluble or particulate matter as is seen in various
foreign body granulomas. There is no palisading of the epithelioid cells peripherally
about a central caseous or necrotic mass with an outside rim of monocytes as is seen
in the tuberculoid granulomas such as tuberculosis, syphilis, and mycotic infections.
There is simply gradual growth and transformation of reticulo-endothelial cefls into
stable epithelioid cefls apparently as a result of antigen-antibody reaction. This is a
focal process at first, perivascular in the main, but ultimately the picture is quite diffuse
with replacement of most or all of the normal tissue. This type of granulomatous
patterning has been referred to as "epithelioid" or "sarcoid" and is seen classically in
such conditions as sarcoidosis and tuberculoid leprosy. It is not possible at this time to
state that these diseases, which resemble the allergic zirconium deodorant granuloma
histologically, are necessarfly totally allergic in nature themselves. However, with the
knowledge that a simple chemical, zirconium, can of itself produce the diffuse,
sarcoid-type granuloma as described herein, we should critically evaluate these and
other granulomatous diseases with this possibility in mind. There is some evidence to
indicate that both sarcoidosis and tuberculoid leprosy do represent allergic granulomas
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in the strict sense. Support for such a view is found in the Kveim test, in which the
intradermal injection of a 10% saline suspension of sarcoid tissue produces a granulomatous papule at three to five weeks in most cases of sarcoidosis. The allergen or
granulomagenic material in the Kveim antigen has not yet been identified. Similarly,
intradermal inoculation of a phenolized, ground-up suspension of lepra bacifli wfll
produce, in patients with tuberculoid leprosy (but not in those with lepromatous
leprosy), a granulomatous papule at three weeks. This reaction, known as the Mitsuda
reaction, is an aid in the diagnosis of tuberculoid leprosy and indicates a hypersensitivity
of these patients to some fraction of the mycobacteria. Beryllium and sflicon granulomas
also may represent allergic granulomas and should be investigated from this standpoint.
Intradermal testing with dflutions of beryllium or siflcon salts might well indicate that
these patients have a hypersensitivity to these metals which could be responsible for
their granulomas.
It is not necessary to postulate an aflergic mechanism to explain the pathogenesis
of foreign body granulomas since the process seems to be simply one of phagocytosis
of the foreign material by the reticulo-endothelial cells. Extensive discussion of the
possible importance of an allergic process in the development of the tuberculoid granulomas is not within the scope of this paper. Patients with tuberculosis, deep fungous
infections, syphilis, do have an associated allergic hypersensitivity, as indicated by a
tuberculin-type (48 hours) response to skin test antigen preparations of the various
organisms. However, this allergic response is not granulomatous in nature and, unlike
the Kveim or Mitsuda reactions, does not necessarily indicate that a granulomatous
stage of the disease is present. As exemplified by the Mantoux tuberculin test, a
positive skin test merely indicates previous exposure and sensitization (with the tuberculin-type allergy) to the purified protein derivative of the tubercle bacillus. The
pathogenesis of the tuberculoid granulomas does not seem to have been satisfactorily
explained on the basis of secondary reaction to the organisms themselves, their products,
or as a result of tissue destruction^". Its elucidation awaits further study.
Summary
A new dermatologic entity, the zirconium deodorant granuloma, has been
described and experimental and clinical studies regarding its pathogenesis reviewed.
It has been shown that the zirconium deodorant granuloma is the result of an allergic
hyperesensflivity on the part of the affected individuals to the metal, zirconium, which
manifests itself as a granuloma. This, to our knowledge, is the first demonstration in
man, that an allergic processs can be responsible for the development of a granuloma.
The significance of this new form of allergy in relation to other granulomatous disorders in medicine is discussed.
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